— Know what they know.
Not Investment Advice
Also trades as: EPIGRAL.NS (NSE) · $vol 1M

EPIGRAL.BO BSE

Epigral Limited
1W: -8.2% 1M: -19.9% 3M: -4.2% YTD: -5.5% 1Y: -47.2% 3Y: +4.2%
₹1,017.00 ($10.55)
+33.60 (+3.42%)
 
BSE · Basic Materials · Chemicals · Tech Score Strong Sell · Power 25 · ₹42.9B mcap · 13M float · 0.028% daily turnover

Cash Flow Trends

Operating Cash Flow
$3.9B -12.0% ▼
5Y CAGR: +11.1%
Capital Expenditures
$3.9B -102.5% ▼
5Y CAGR: +14.9%
Free Cash Flow
-$65M -102.7% ▼
Dividends Paid
$183M +56.2% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$167M -208.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$3.8B$5.2B$2.9B$3.6B$3.3B
Depreciation & Amort.$859M$1.1B$1.2B$1.3B$1.7B
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$1.7B$408M-$384M-$1.7B-$644M
Other Non-Cash Items-$161M-$461M$218M$1.2B-$483M
Operating Cash Flow$2.8B$6.3B$4.0B$4.4B$3.9B
— Investing Activities —
Capital Expenditures-$4.6B-$4.2B-$4.0B-$1.9B-$3.9B
Acquisitions (Net)-$500K-$205M$0$0$87M
Investment Purchases-$14M-$2M$0$0-$1.5B
Investment Sales$14M$8M$0$0$1.8B
Other Investing$17M-$9M-$27M-$669M$0
Investing Cash Flow-$4.5B-$4.4B-$4.0B-$2.6B-$3.6B
— Financing Activities —
Net Debt Issuance$2.4B-$1.1B$1.5B-$2.8B-$216M
Stock Repurchased$0-$609M-$550M-$950M$0
Dividends Paid$0-$242M-$251M-$419M-$183M
Other Financing-$491M-$9M-$735M-$683M-$59M
Financing Cash Flow$2.0B-$2.0B-$76M-$1.6B-$458M
Net Change in Cash$244M-$108M-$111M$155M-$167M
Cash End of Period$251M$142M$32M$186M$55M
Free Cash Flow-$1.7B$2.1B-$8M$2.5B-$65M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms